{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:42:21Z","timestamp":1788392541066,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12872-016-0454-5","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T09:49:32Z","timestamp":1483609772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Impact of diabetes and hypertension on cardiovascular outcomes in patients with coronary artery disease receiving percutaneous coronary intervention"],"prefix":"10.1186","volume":"17","author":[{"given":"Mao-Jen","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hau-De","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,5]]},"reference":[{"issue":"20","key":"454_CR1","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/CIRCULATIONAHA.106.667915","volume":"114","author":"DO Williams","year":"2006","unstructured":"Williams DO, Abbott JD, Kip KE. DEScover investigators. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry. Circulation. 2006;114(20):2154\u201362.","journal-title":"Circulation"},{"issue":"4","key":"454_CR2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00380-011-0169-6","volume":"27","author":"C Lazzeri","year":"2012","unstructured":"Lazzeri C, Valente S, Chiostri M, Attana P, Picariello C, Gensini GF. Impact of hypertension on short and long- term prognoses in patients with ST elevation myocardial infarction and without previously known diabetes. Heart Vessels. 2012;27(4):370\u20136.","journal-title":"Heart Vessels"},{"issue":"1","key":"454_CR3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40292-013-0032-1","volume":"21","author":"E Cecchi","year":"2014","unstructured":"Cecchi E, D\u2019Alfonso MG, Chiostri M, Parigi E, Landi D, Valente S, et al. Impact of hypertension history on short and long-term prognosis in patients with acutemyocardial infarctioon treated with percutaneous angioplasty: comparison between STEMI and NSTEMI. High Blood Press Cardiovasc Prev. 2014;21(1):37\u201343.","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"10","key":"454_CR4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0300-8932(03)76996-6","volume":"56","author":"JR Lopez Minguez","year":"2003","unstructured":"Lopez Minguez JR, Fuentes ME, Doblado MI, Merch\u00e1n A, Marti\u0144ez A, Gonz\u00e1lez R, et al. Prognostic role of systemic hypertension and diabetes mellitus in patients with unstable angina undergoing coronary stenting. Rev Esp Cardiol. 2003;56(10):987\u201394.","journal-title":"Rev Esp Cardiol"},{"issue":"1","key":"454_CR5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4244\/EIJV10I1A15","volume":"10","author":"LP Hoebers","year":"2014","unstructured":"Hoebers LP, Claessen BE, Woudstra P, DVries JH, Wykrzykowska JJ, Vis MM, et al. Long-term mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in patients with insulin-treated versus non-insulin\u2013treated diabetes mellitus. Eurointervention. 2014;10(1):90\u20136.","journal-title":"Eurointervention"},{"key":"454_CR6","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ijcard.2014.10.116","volume":"179","author":"R Klempfner","year":"2015","unstructured":"Klempfner R, Elis A, Matezky S, Keren G, Roth A, Finkelstein A, et al. Temporal trends in management and outcome of diabetic and nn-diabetic patients with acute coronary syndrome (ACS): residual risk of long-term mortality persists: insight from the ACS Israeli Survey (ACSIS) 2000\u20132010. Int J Cardiol. 2015;179:546\u201351.","journal-title":"Int J Cardiol"},{"issue":"2","key":"454_CR7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3904\/kjim.2012.27.2.180","volume":"27","author":"KH Park","year":"2012","unstructured":"Park KH, Ahn Y, Jeong MH, Chae SC, Hur SH, Kim YJ, et al. Different impact of diabetes mellitus on in-hospital and 1-year mortality in patients with acute myocardial infarction intervention: results from the Koran Acute Myocardial Infarction Registry. Korean J Intern Med. 2012;27(2):180\u20138.","journal-title":"Korean J Intern Med"},{"issue":"5","key":"454_CR8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.amjcard.2011.10.018","volume":"109","author":"LO Jensen","year":"2012","unstructured":"Jensen LO, Maeng M, Thayssen P, Tilsted HH, Terkelsen CJ, Kaltoft A, et al. Influence of diabetes on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Am J Cardiol. 2012;109(5):629\u201335.","journal-title":"Am J Cardiol"},{"issue":"1","key":"454_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1479164111427752","volume":"9","author":"MB Kahn","year":"2012","unstructured":"Kahn MB, Cubbon RM, Mercer B, Wheatcroft AC, Gherardi G, Aziz A, et al. Association of diabetes with increased all-cause mortality following primary percutaneous coronary intervention for ST-segmenty elevatin myocardial infarction in the contemporary era. Diab Vas Dis Res. 2012;9(1):3\u20139.","journal-title":"Diab Vas Dis Res"},{"issue":"4","key":"454_CR10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jjcc.2012.06.003","volume":"60","author":"MG Lee","year":"2012","unstructured":"Lee MG, Jeong MH, Lee KH, Park SH, Sim DS, Yoon HJ, et al. Prognostic impact of diabetes and hypertension for mid-term outcome of patients with acute myocardial infarction who underwent percutaneous coronary intervention. J Cardiol. 2012;60(4):257\u201363.","journal-title":"J Cardiol"},{"issue":"4","key":"454_CR11","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.CIR.0000109693.64957.20","volume":"109","author":"V Mathew","year":"2004","unstructured":"Mathew V, Gersh BJ, Williams BA, Laskey WK, Willerson JT, Tilbury RT, et al. Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of ReStenosis with tranilast and its outcome (PRESTO) trial. Circulation. 2004;109(4):476\u201380.","journal-title":"Circulation"},{"issue":"10","key":"454_CR12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0002-9149(02)02770-4","volume":"90","author":"WK Laskey","year":"2002","unstructured":"Laskey WK, Selzer F, Vlachos HA, Johnston J, Jacobs A, King 3rd SB, et al. Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung and Blood Institute Dynamic Registry). Am J Cardiol. 2002;90(10):1062\u20137.","journal-title":"Am J Cardiol"},{"issue":"10","key":"454_CR13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","volume":"360","author":"PW Serruys","year":"2009","unstructured":"Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. SYNTAX investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961\u201372.","journal-title":"N Engl J Med"},{"key":"454_CR14","doi-asserted-by":"crossref","unstructured":"American Diabetic Association. Diagnosis and classification of Diabetes Mellitus. Diabetes Care. 2013;36 Supplement 1:S67-S74.","DOI":"10.2337\/dc13-S067"},{"key":"454_CR15","first-page":"S1","volume":"42","author":"National Kidney Foundation, Kidney Disease Outcome Quality Initiative (K\/DOQI)","year":"2003","unstructured":"National Kidney Foundation, Kidney Disease Outcome Quality Initiative (K\/DOQI). Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kid Dis. 2003;42:S1\u2013201.","journal-title":"Am J Kid Dis"},{"issue":"25","key":"454_CR16","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"CP Cannon","year":"2015","unstructured":"Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372(25):2387\u201397.","journal-title":"N Engl J Med"},{"issue":"10","key":"454_CR17","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/ehjci\/jev283","volume":"17","author":"M Iannaccone","year":"2016","unstructured":"Iannaccone M, Quadri G, Taha S, D\u2019Ascenzo F, Montefusco A, Omede\u2019 P, et al. Prevalence and predictors of culprit plaque rupture at OCT in patients with coronary artery disease: a meta-analysis. Eur Heart J Cardiovasc Imaging. 2016;17(10):1128\u201337.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"454_CR18","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(05)67186-3","volume":"366","author":"NR Poulter","year":"2005","unstructured":"Poulter NR, Wedel H, Dahl\u00f6f B, Server PS, Beevers DG, Caulfield M, et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet. 2005;366:907\u201313.","journal-title":"Lancet"},{"key":"454_CR19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"PS Sever","year":"2003","unstructured":"Sever PS, Dahl\u00f6f B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomized controlled trial. Lancet. 2003;361:1149\u201358.","journal-title":"Lancet"},{"issue":"7","key":"454_CR20","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/eurheartj\/ehi809","volume":"27","author":"JW Deckers","year":"2006","unstructured":"Deckers JW, Goedhart DM, Boersma E, Briggs A, Bertrand M, Ferrari R, et al. Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk. Eur Heart J. 2006;27(7):796\u2013801.","journal-title":"Eur Heart J"},{"issue":"3","key":"454_CR21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):145\u201353.","journal-title":"N Engl J Med"},{"key":"454_CR22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","volume":"360","author":"Heart Protection Study collaborativer Group","year":"2002","unstructured":"Heart Protection Study collaborativer Group. MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7\u201322.","journal-title":"Lancet"},{"key":"454_CR23","doi-asserted-by":"crossref","unstructured":"The Long-Term Intervention with Pravastatin in Ischaemic Disease(LIPID) Study Group.Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998;339(19):1349-57.","DOI":"10.1056\/NEJM199811053391902"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-016-0454-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T03:19:37Z","timestamp":1498360777000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-016-0454-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,5]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["454"],"URL":"https:\/\/doi.org\/10.1186\/s12872-016-0454-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,5]]},"article-number":"12"}}